NCT01235455View on ClinicalTrials.gov

Portuguese Observational Survey to Assess Drug Adherence in Patients With Multiple Sclerosis After Conversion to Betaferon by Using Elements of the BetaPlus Program - Nurse Support, Auto-injectors

CompletedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

August 31, 2007

Study Completion Date

May 31, 2011

Conditions
Relapsing Remitting Multiple Sclerosis (RRMS)Secondary Progressive Multiple Sclerosis (SPMS)
Interventions
DRUG

Interferon beta-1b (Betaseron, BAY86-5046)

250 µg, sub-cutaneously, on alternate days

Trial Locations (1)

Unknown

Many Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT01235455 - Portuguese Observational Survey to Assess Drug Adherence in Patients With Multiple Sclerosis After Conversion to Betaferon by Using Elements of the BetaPlus Program - Nurse Support, Auto-injectors | Biotech Hunter | Biotech Hunter